ACAT NP Life Sciences Health Industry Group Inc.

Fundamentals / CIK 0001781726 / USD

NP Life Sciences Health Industry Group Inc. reported $165K in revenue and a net loss of $2.9K for the fiscal year ended December 31, 2023 (up 61.4% year over year), with a -0.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACAT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2019 to 2023), reported in USD.

$176K$88K$0-$137KFY 2019 Revenue: $43KFY 2019 Net Income: -$109K2019FY 2020 Revenue: $15KFY 2020 Net Income: -$131K2020FY 2021 Revenue: $35KFY 2021 Net Income: -$66K2021FY 2022 Revenue: $102KFY 2022 Net Income: -$19K2022FY 2023 Revenue: $165KFY 2023 Net Income: -$2.9K2023

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $165K $102K $35K $15K $43K
Operating Income -$690 -$19K -$66K -$131K -$109K
Interest Income -- -- $4 $26 $32
Interest Expense $645 $1 -- -- --
Income Before Tax -$1.3K -$19K -$66K -$131K -$109K
Income Tax Expense $1.6K -- -- -- --
Net Income -$2.9K -$19K -$66K -$131K -$109K
Basic EPS $0.00 $0.00 $0.00 $0.00 $0.00
Diluted EPS $0.00 $0.00 $0.00 $0.00 $0.00
Basic Shares Outstanding 43.0M 43.0M 43.0M 43.0M 34.1M
Diluted Shares Outstanding 43.0M 43.0M 43.0M 43.0M 34.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Revenue $10K $18K $107K $30K -- $41K $15K --
Operating Income -$36K -$37K $71K $1.2K $17K -$5.4K $1.1K -$31K
Interest Income -- -- -- -- -- -- $1 --
Income Before Tax -$37K -$37K -- $1.2K $17K -$5.4K $1.1K -$31K
Net Income -$15K -$38K $71K $1.2K $17K -$5.4K $1.1K -$31K
Basic EPS -- -- -- $0.00 -- -- -- $0.00
Basic Shares Outstanding -- 43.0M 43.0M 43.0M -- 43.0M 43.0M 43.0M
Diluted Shares Outstanding -- 43.0M 43.0M -- -- 43.0M 43.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $71K $122K $28K $119K $243K $200
Cash & Short-Term Investments $71K $122K $28K $119K $243K $200
Total Current Assets -- -- -- -- -- $200
Intangible Assets -- -- -- -- $7.2K --
Total Non-Current Assets -- -- -- -- -- $0
Total Assets $77K $128K $38K $119K $250K $200
Accounts Payable $6.1K $6.1K -- -- $1.0K $466
Deferred Revenue (Current) -- $100K -- -- -- --
Total Current Liabilities $38K $108K -- -- -- --
Total Non-Current Liabilities $22K $0 -- -- -- --
Total Liabilities $60K $108K $239 $15K $15K $21K
Common Stock $4.3K $4.3K $4.3K $4.3K $4.4K $7
Retained Earnings -$348K -$345K -$326K -$261K -$130K -$21K
Total Stockholders' Equity -- $19K $38K $104K $235K -$21K
Total Equity $16K $19K $38K $104K $235K -$21K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Cash & Cash Equivalents $71K $85K $125K $140K $122K $7.0K $575 $23K
Cash & Short-Term Investments $71K $85K $125K $140K $122K $7.0K $575 $23K
Total Assets $77K $95K $144K $142K $128K $17K $17K $25K
Accounts Payable $6.1K $6.0K $6.0K $6.0K $6.1K $9.2K $3.9K --
Deferred Revenue (Current) -- $10K $7.5K $113K $100K -- -- $15K
Total Current Liabilities $38K -- -- -- $108K -- -- --
Total Non-Current Liabilities $22K -- -- -- $0 -- -- --
Total Liabilities $60K $64K $77K $122K $108K $14K $8.9K $18K
Common Stock $4.3K $4.3K $4.3K $4.3K $4.3K $4.3K $4.3K $4.3K
Retained Earnings -$348K -$333K -$298K -$344K -$345K -$362K -$356K -$358K
Total Stockholders' Equity -- $32K $67K $21K $19K $2.7K $8.2K $7.1K
Total Equity $16K $32K $67K $21K $19K $2.7K $8.2K $7.1K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$2.9K -$19K -$66K -$131K -$109K
Change in Payables -- $6.1K -- -$1.0K $565
Operating Cash Flow -$74K $94K -$91K -$124K -$4.3K
Investing Cash Flow -- -- -- -- -$8.6K
Common Stock Issued -- -- -- -- $364K
Financing Cash Flow $22K -- -- -- $364K
Net Change in Cash -$51K $94K -$91K -$124K $243K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Net Income -$15K -$38K $71K $1.2K $17K -$5.4K $1.1K -$31K
Change in Payables -- $0 $0 -$105 -- -- -- --
Operating Cash Flow -$14K -$41K -$37K $18K $115K $6.4K -$23K -$4.9K
Net Change in Cash -$14K -$41K -$15K $18K $115K $6.4K -$23K -$4.9K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -0.4% -18.5% -187.7% -873.9% -253.2%
Net Profit Margin -1.8% -18.5% -187.7% -873.8% -253.1%
Return on Equity (ROE) -- -97.6% -172.1% -126.2% -46.3%
Return on Assets (ROA) -3.8% -14.8% -171.0% -110.5% -43.5%
Quick Ratio 1.85x 1.12x -- -- --
Revenue Growth (YoY) +61.4% +191.5% +133.3% -65.1% --
Operating Cash Flow Growth (YoY) -178.4% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Operating Margin -0.4% -- -- -- -- -- -- --
Net Profit Margin 11.8% -- -- -- -- -- -- --
Return on Equity (ROE) -- 161.8% 124.5% 65.5% -97.6% -117.2% -227.7% -1022.6%
Return on Assets (ROA) 25.2% 53.9% 58.0% 9.4% -14.8% -18.8% -109.1% -291.9%
Quick Ratio 1.85x -- -- -- 1.12x -- -- --
Revenue Growth (YoY) -- -57.3% +614.9% -- -- -- -- --
Operating Income Growth (YoY) -316.0% -- +6528.8% -- -48.6% -- -- --
Net Income Growth (YoY) -192.5% -- +6504.4% -- -48.6% -- -- --
Operating Cash Flow Growth (YoY) -112.1% -736.1% -- -- +3761.2% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001781726) · from December 31, 2018 Data through December 31, 2023 · synced Nov 20, 2026, 05:37 UTC · Open in terminal